BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1305034)

  • 1. Selective inhibition of in vitro cell growth by the anti-tumour drug Ukrain.
    Hohenwarter O; Strutzenberger K; Katinger H; Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1992; 18 Suppl():1-4. PubMed ID: 1305034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of apoptosis in cultured Chinese hamster ovary cells by Ukrain and its synergistic action with etoposide.
    Kurochkin SN; Kolobkov SL; Votrin II; Voltchek IV
    Drugs Exp Clin Res; 2000; 26(5-6):275-8. PubMed ID: 11345038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ukrain, an alkaloid thiophosphoric acid derivative of Chelidonium majus L. protects human fibroblasts but not human tumour cells in vitro against ionizing radiation.
    Cordes N; Plasswilm L; Bamberg M; Rodemann HP
    Int J Radiat Biol; 2002 Jan; 78(1):17-27. PubMed ID: 11747550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2 overexpression protects human keratinocyte cells from Ukrain-induced apoptosis but not from G2/M arrest.
    Roublevskaia IN; Haake AR; Polevoda BV
    Drugs Exp Clin Res; 2000; 26(5-6):149-56. PubMed ID: 11345021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies concerning the effect of Ukrain in vivo and in vitro.
    Brüller W
    Drugs Exp Clin Res; 1992; 18 Suppl():13-6. PubMed ID: 1305037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of macrophage tumouricidal activity by the alkaloid derivative Ukrain. In vitro and in vivo studies.
    Sotomayor EM; Rao K; Lopez DM; Liepins A
    Drugs Exp Clin Res; 1992; 18 Suppl():5-11. PubMed ID: 1305044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ukrain: a novel antitumor drug.
    Uglyanitsa KN; Nefyodov LI; Doroshenko YM; Nowicky JW; Volchek IV; Brzosko WJ; Hodysh YJ
    Drugs Exp Clin Res; 2000; 26(5-6):341-56. PubMed ID: 11345050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced apoptosis in human prostate cancer cell line LNCaP by Ukrain.
    Roublevskaia IN; Haake AR; Ludlow JW; Polevoda BV
    Drugs Exp Clin Res; 2000; 26(5-6):141-7. PubMed ID: 11345020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergic influence of Ukrain and protoporphyrin amino acid conjugates on human malignant cell lines.
    Brzosko WJ; Graczyk A; Konarski J; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):193-4. PubMed ID: 8899329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Ukrain on human liver alcohol dehydrogenase activity in vitro.
    Jagiełło-Wójtowicz E; Dudka J; Dawidek-Pietryka K
    Drugs Exp Clin Res; 2000; 26(5-6):337-9. PubMed ID: 11345049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of NSC-631570 (ukrain) alone and in combination with pathogen-associated molecules on cell cycle distribution and apoptosis induction of mouse melanoma cells with different biological properties.
    Skivka LM; Trompak OO; Kudryavets YI; Bezdenezhnykh NA; Susak YM
    Exp Oncol; 2010 Jul; 32(2):92-6. PubMed ID: 20693969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice.
    Poteryaeva ON; Falameyeva OV; Korolenko TA; Kaledin VI; Djanayeva SJ; Nowicky JW; Sandula J
    Drugs Exp Clin Res; 2000; 26(5-6):301-6. PubMed ID: 11345042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Ukrain on the activities of DNA-nicking enzymes.
    Votrin II; Voltchek IV; Kurochkin SN; Kolobkov SL
    Drugs Exp Clin Res; 2000; 26(5-6):267-73. PubMed ID: 11345037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ukrain both as an anti cancer and immunoregulatory agent.
    Nowicky JW; Manolakis G; Meijer D; Vatanasapt V; Brzosko WJ
    Drugs Exp Clin Res; 1992; 18 Suppl():51-4. PubMed ID: 1305045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dynamics of concentration of the main fluorescent component of Ukrain in the tissues and blood plasma of rats with W-256 tumor after a single intravenous injection.
    Doroshenko YM; Karavay AV; Hodysh YY; Uglyanitsa KN; Nowicky WM; Nefyodov LI
    Drugs Exp Clin Res; 2000; 26(5-6):171-7. PubMed ID: 11345024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of bimodal programmed cell death in malignant cells by the derivative Ukrain (NSC-631570).
    Liepins A; Nowicky JW; Bustamante JO; Lam E
    Drugs Exp Clin Res; 1996; 22(3-5):73-9. PubMed ID: 8899308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ukrain (NSC-631570) in experimental and clinical studies: a review.
    Jagiello-Wójtowicz E; Kleinrok Z; Urbanska EM
    Drugs Exp Clin Res; 1998; 24(5-6):213-9. PubMed ID: 10190077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ukrain(TM), a semisynthetic Chelidonium majus alkaloid derivative, acts by inhibition of tubulin polymerization in normal and malignant cell lines.
    Panzer A; Hamel E; Joubert AM; Bianchi PC; Seegers JC
    Cancer Lett; 2000 Nov; 160(2):149-57. PubMed ID: 11053644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway.
    Habermehl D; Kammerer B; Handrick R; Eldh T; Gruber C; Cordes N; Daniel PT; Plasswilm L; Bamberg M; Belka C; Jendrossek V
    BMC Cancer; 2006 Jan; 6():14. PubMed ID: 16417634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.